Recent Updates
Recently added Catalysts
FULC Positive Sentiment Score: 70/100

Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET

Tuesday, February 18, 2025 1 min read
Key Takeaway: Fulcrum Therapeutics, Inc. has scheduled the release of its fourth quarter and full year 2024 financial results on February 25, 2025. Prior to the U.S. financial markets opening, management will host a conference call and webcast at 8:00 a.m. ET to discuss these results. Participants can register for the call and will receive unique access details. An archived replay of the webcast will also be made available following the live event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of Q4 and full year 2024 financial results demonstrates transparency.
  • The company's focus on genetically defined rare diseases highlights its niche expertise.
  • The provision of a conference call allows for engagement with investors.

Full Press Release Details

CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its fourth quarter and full year 2024 financial results will be released on Tuesday, February 25, 2025, before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.
Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s website at www.fulcrumtx.com or by clicking here. Following the live webcast, an archived replay will also be available.
About Fulcrum Therapeutics
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com

Frequently Asked Questions

When will Fulcrum Therapeutics release its 2024 financial results?

Fulcrum Therapeutics will release its 2024 financial results on February 25, 2025.

What time is the conference call for Fulcrum Therapeutics' results?

The conference call is scheduled for 8:00 a.m. ET on February 25, 2025.

How can I access the Fulcrum Therapeutics conference call?

Register via the provided link to receive dial-in details for the call.

Is there a webcast available for the financial results discussion?

Yes, an audio webcast will be available on Fulcrum's Investor Relations website.

Will there be a recording of the conference call?

Yes, an archived replay of the webcast will be available after the live event.

Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics financial results conference call rare diseases
Last updated: Feb 18, 2025